DUBLIN, August 6, 2013 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/7ldcr3/north_american) have announced the addition of the "North American Drug Delivery Technologies Market - Forecasts To 2017" report to their offering.
The North American drug delivery market was estimated to be worth $66.7 billion in 2012, and is expected to register a CAGR of 8.9% between 2012 and 2017
'North American Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts to 2017'
This research report categorizes and analyzes the North American Drug Delivery Technologies market on the basis of routes of administration. These markets are further divided into segments and sub-segments, to provide exhaustive value analysis for the years 2010, 2011, 2012, and forecast to 2017. Each market is comprehensively analyzed at a granular level by country (U.S and Canada), to provide in-depth information on the North American market scenario.
The patent expiry of major blockbuster drugs is a prime concern for pharmaceutical companies, as developing a new chemical entity (NCE) is more expensive and time consuming than a novel drug delivery technology. Therefore, in recent years, several pharmaceutical companies have employed drug delivery technology as a life cycle management tool for some of their blockbuster drugs, the patents for which are set to expire in the near future.
Based on the route of administration, the drug delivery market has been classified as oral, pulmonary, injectable, transdermal, implantable, ocular, nasal, transmucosal, and topical. In 2012, oral drug delivery segment dominated the market with a share of approximately 38%, followed by pulmonary drug delivery segment with a 20% share.
The drug delivery technologies that have recently gained importance in the North American market include orodispersible tablet (ODT), dry powder inhalers, transdermal patches, needle-free injectors, auto and pen injectors, and buccal transmucosal tablets; controlled release is the most widely accepted technology. The use of implantable devices for drug delivery is also on a rise.
Big pharmaceutical companies such as Pfizer and Merck have established in-house capabilities for the development of drug delivery technologies. On the other hand, many companies are still relying on specialty companies engaged in the development of drug delivery technologies. A high level of competition and increasing need for outsourcing has resulted in the fragmentation of the drug delivery market, with several small companies developing novel drug delivery technologies for niche therapeutic applications.
The North American drug delivery market is largely dominated by the U.S. (accounting for about 89% of the overall market). The key drivers for the U.S. drug delivery market are the well established pharmaceutical industry, healthcare reforms, and favourable changes in the FDA review process. Factors such as low cost drug manufacturing and a rising number of drug delivery formulations and devices are propelling the Canadian market.
Key Topics Covered:
2 Executive Summary
3 Market Overview
4 North America Drug Delivery Market, By Technology
4.2 Opportunity Matrix
4.3 Oral Drug Delivery
4.4 Pulmonary Drug Delivery
4.5 Transdermal Drug Delivery
4.6 Injectable Drug Delivery
4.7 Ocular Drug Delivery
4.8 Nasal Drug Delivery
4.9 Topical Drug Delivery
4.10 Implantable Drug Delivery
4.11 Transmucosal Drug Delivery
5 Geographic Analysis
6 Competitive Landscape
7 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)*
- Aptalis Pharma, Inc
- Baxter International, Inc
- Becton, Dickinson And Company
- Catalent Pharma Solutions
- Cima Labs
- Endo Health Solutions, Inc
- Johnson & Johnson, Inc
- M Company
- Nektar Therapeutics, Inc
- Optinose As
- Psivida Corporation
- The Dow Chemical Company
- Valeant Pharmaceuticals
For more information visit http://www.researchandmarkets.com/research/7ldcr3/north_american
|SOURCE Research and Markets|
Copyright©2012 PR Newswire.
All rights reserved